Preparedness for the future in patients with relapsed or refractory hematopoietic malignancies in the treatment process: a qualitative study
Annals of Palliative Medicine · 2025
DOI: 10.21037/apm-24-124 ↗Kurz gefasst
Qualitative Studie in der Zeitschrift Annals of Palliative Medicine, 2025. Verfasst von Kazuko Akashi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nursing, Fuchu Hospital, Osaka, Japan; Graduate School of Biomedical Sciences, The University of Tokushima, Tokushima, Japan. Hauptthemen laut MEDLINE: Hematologic Neoplasms.
Abstract (Originalsprache)
BACKGROUND: This study aims to clarify how patients with relapsed or refractory (R/R) hematological malignancies prepare for the future and set treatment goals. R/R hematological malignancies often require intensive therapies, including stem cell transplantation and CAR-T cell therapy, which pose high risks of adverse events. Many patients continue aggressive treatment until the end of life for pain relief or even a potential cure, despite the significant symptom burden. Understanding each patient's treatment motivations and preferences is essential to aligning care with their individual values. By examining their experiences, current health status, and treatment goals, this study seeks to provide a basis for holding early discussions on future care, contributing to individualized decision-making support for patients facing limited treatment options and uncertain prognoses. METHODS: A qualitative descriptive study design was used to conduct semi-structured interviews with 16 patients with relapsed/refractory hematopoietic malignancies who were hospitalized for chemotherapy. RESULTS: The four main themes expressed by the participants were (I) I want to live through the treatment until the end of my life because I know recovery is difficult; (II) my current treatment depends on how much my body can endure; (III) I want to keep trying, but I am at the limit of what I can do now; and (IV) I want to continue even if the treatment is limited because I think it will help someone else. CONCLUSIONS: Patients with hematopoietic malignancies who are undergoing treatment may be motivated by a variety of different factors to continue with treatment. Discussing patients' goals and wishes with respect to treatment is critically important to ensure that such treatment is aligned with patients' preferences.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Nursing, Fuchu Hospital, Osaka, Japan; Graduate School of Biomedical Sciences, The University of Tokushima, Tokushima, Japan.
- Faculty of Biomedical Sciences, Department of Cancer Nursing, Graduate School, The University of Tokushima, Tokushima, Japan.
- Department of Community Medicine and Medical Science, Graduate School, The University of Tokushima, Tokushima, Japan.
- Department of Hematology, Endocrinology and Metabolism, Graduate School, The University of Tokushima, Tokushima, Japan.
- Division of Transfusion Medicine and Cell Therapy, Tokushima University Hospital, Tokushima, Japan.
Zitieren
APA
Akashi, K., Imai, Y., Nakamura, S., Maeda, Y., Sumitani, R., Oura, M., Sogabe, K., Takahashi, M., Fujii, S., Harada, T., & Miki, H. (2025). Preparedness for the future in patients with relapsed or refractory hematopoietic malignancies in the treatment process: a qualitative study. Annals of Palliative Medicine. https://doi.org/10.21037/apm-24-124
Vancouver
Akashi K, Imai Y, Nakamura S, Maeda Y, Sumitani R, Oura M, et al. Preparedness for the future in patients with relapsed or refractory hematopoietic malignancies in the treatment process: a qualitative study. Annals of Palliative Medicine. 2025. doi:10.21037/apm-24-124
BibTeX
@article{Akashi2025,
author = {Akashi, Kazuko and Imai, Yoshie and Nakamura, Shingen and Maeda, Yusaku and Sumitani, Ryohei and Oura, Masahiro and Sogabe, Kimiko and Takahashi, Mamiko and Fujii, Shiro and Harada, Takeshi and Miki, Hirokazu},
title = {Preparedness for the future in patients with relapsed or refractory hematopoietic malignancies in the treatment process: a qualitative study},
journal = {Annals of Palliative Medicine},
year = {2025},
doi = {10.21037/apm-24-124}
}
EUVIMED